-
1.
公开(公告)号:US20240358751A1
公开(公告)日:2024-10-31
申请号:US18681641
申请日:2022-08-19
IPC分类号: A61K35/15 , A61P25/28 , C12N5/0786
CPC分类号: A61K35/15 , A61P25/28 , C12N5/0645 , C12N2501/115 , C12N2501/125 , C12N2501/145 , C12N2501/15 , C12N2501/155 , C12N2501/165 , C12N2501/22 , C12N2501/2303 , C12N2501/2334 , C12N2501/26 , C12N2501/845 , C12N2506/45
摘要: Mononuclear phagocytes derived from induced pluripotent stem cells, denoted as iMPs, which comprise monocytes generated from the induced pluripotent stem cells and optionally further macrophages generated from the induced pluripotent stem cells, are provided for use in improving cognitive function, improving neural health, and/or alleviating or treating a neurodegenerative disorder in a mammal In various embodiments, the iMPs produce macrophages after transplantation or after being stimulated in vitro, and/or express macrophage markers. We showed that iMPs upon administration improve cognition and neural healthy in rodent models of aging, Alzheimer's disease, and amyotrophic lateral sclerosis. Treatment methods are also provided using mononuclear phagocytes generated from autologous stem cells or from induced pluripotent stem cells obtained from autologous cells in patients in need of treatment or prophylaxis of a neurodegenerative disorder.
-
公开(公告)号:US20240336691A1
公开(公告)日:2024-10-10
申请号:US18546947
申请日:2022-02-17
发明人: Allison LUO , Olivier LAURENT , Ernesto J. MUNOZ , Janine BILSBOROUGH , Bradley HENKLE , Stephan R. TARGAN , Dermot P. MCGOVERN
CPC分类号: C07K16/2875 , A61K47/02 , A61K47/12 , A61K47/183 , A61K47/22 , A61K47/26 , A61P11/00 , C07K2317/21
摘要: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of diseases and/or conditions in the lung.
-
公开(公告)号:US12102414B2
公开(公告)日:2024-10-01
申请号:US16489334
申请日:2018-02-27
IPC分类号: A61B5/02 , A61B5/00 , A61B5/0205 , A61B5/107 , G16H20/10 , G16H30/40 , G16H50/20 , A61B5/055
CPC分类号: A61B5/02007 , A61B5/0205 , A61B5/1075 , A61B5/489 , G16H20/10 , G16H30/40 , G16H50/20 , A61B5/055
摘要: The invention relates to a method of scanning for vascular ill health using a data set from an in vivo scan, the method including the steps of: (1) extracting blood vessel location data and blood vessel size data from the scan data set; (2) selecting a region in the extracted vessel location data; and (3) comparing the size data in the selected region to size data in a corresponding region of a normative data set to determine vascular health.
-
4.
公开(公告)号:US20240309104A1
公开(公告)日:2024-09-19
申请号:US18546938
申请日:2022-02-17
发明人: Allison LUO , Lauren OTSUKI , Mark MANNING , Robert PAYNE , Olivier LAURENT , Janine BILSBOROUGH , Bradley HENKLE , Stephan R. TARGAN
CPC分类号: C07K16/2875 , A61P1/00 , A61P1/04 , A61K2039/505 , A61K2039/545
摘要: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
-
公开(公告)号:US20240306908A1
公开(公告)日:2024-09-19
申请号:US18577161
申请日:2022-07-08
发明人: Maya Koronyo , Yosef Koronyo , Keith L. Black , Nazanin Mirzaei , Liang Gao
摘要: The present invention describes systems and method for the detection, diagnosis and monitoring of cognitive impairment and Alzheimer's disease. In one example, an integrated system comprising a full-field Fourier domain optical coherence tomography and an image mapping spectrometry is used for generating spectrally resolved volumetric images at wavelengths that show difference in spectral signatures of normal cells compared to spectral signatures of amyloid beta and pTau deposits, and also image inner retinal layers where amyloid beta and pTau deposits may aggregate.
-
公开(公告)号:US20240124573A1
公开(公告)日:2024-04-18
申请号:US18447623
申请日:2023-08-10
发明人: Kevin CHOW , Edward CHONG , Nuala MOONEY , Julien LION , Stanley C. JORDAN
CPC分类号: C07K16/248 , A61P37/06 , A61K2039/505
摘要: Novel therapeutic protocols are provided relating to the use of an anti-IL-6 antibody, e.g., Clazakizumab, in order to prevent, stabilize, reduce or arrest antibody mediated rejection responses in patients receiving solid organ transplants, e.g., patients receiving transplanted kidney, heart, liver, lungs, pancreas, intestines or combinations of any of the foregoing. Also novel therapeutic protocols are provided pertaining to the use of an anti-IL-6 antibody, e.g., Clazakizumab, as part of a desensitization protocol for treating highly sensitized subjects waiting for and/or after allograft transplants, e.g., patients who are to receive solid organ transplants, e.g., kidney, heart, liver, lungs, pancreas, intestines, skin or combinations of any of the foregoing. The foregoing treatments may be effected in combination with one or more other immunosuppressant regimens or other desensitization procedures.
-
公开(公告)号:US20240115569A1
公开(公告)日:2024-04-11
申请号:US18276115
申请日:2022-02-11
发明人: Paul W. Noble , Dianhua Jiang
IPC分类号: A61K31/517 , A61K47/68 , A61P11/00
CPC分类号: A61K31/517 , A61K47/6803 , A61P11/00
摘要: The invention of the present disclosure relates to methods for diagnosing and for treating a progressive lung disease in a subject. In various embodiments, the method for treating a progressive lung disease in a subject includes administering a pharmaceutical composition comprising a Human Epidermal Growth Factor Receptor 2 (HER2) blocking agent and a pharmaceutically acceptable carrier to the subject, wherein the method improves clinical outcome compared to an untreated control.
-
公开(公告)号:US20240095912A1
公开(公告)日:2024-03-21
申请号:US18367154
申请日:2023-09-12
发明人: Piotr SLOMKA , Aakash Shanbhag
IPC分类号: G06T7/00
CPC分类号: G06T7/0012 , G06T2207/10108 , G06T2207/20081 , G06T2207/30048
摘要: Systems and methods are disclosed for applying attenuation correction to single photon emission computed tomography (SPECT) imaging data for myocardial perfusion imaging (MPI) studies. SPECT-MPI imaging data can be provided to a deep-learning model to automatically generate simulated computed tomography attenuation correction (CT-AC) images from the non-corrected (NC) SPECT-MPI imaging data. These simulated CT-AC images can then be used to perform attenuation correction on the SPECT-MPI imaging data to generate corrected SPECT-MPI imaging data. The deep-learning model can be trained using corresponding pairs of non-corrected SPECT-MPI imaging data and traditional CT-AC imaging data. The deep-learning model can be a conditional generative adversarial neural network (cGAN).
-
公开(公告)号:US11913022B2
公开(公告)日:2024-02-27
申请号:US16480778
申请日:2018-01-25
发明人: Ying Qu , Xiaojiang Cui , Dhruv Sareen , Armando E. Giuliano
CPC分类号: C12N5/0631 , A61K35/55 , C12N5/0696 , C12N2506/45 , C12N2533/54 , C12N2533/90
摘要: Human induced pluripotent stem cells (iPSCs) can give rise to multiple cell types and hold great promise in regenerative medicine and disease modeling applications. The Inventors herein developed a reliable two-step protocol to generate human mammary-like organoids from iPSCs. Non-neural ectoderm cell-containing spheres, referred to as mEBs, were first differentiated and enriched from iPSCs using MammoCult medium. Gene expression profile analysis suggested that mammary gland function-associated signaling pathways were hallmarks of 10-d differentiated mEBs. The Inventors generated mammary-like organoids from 10-d mEBs using 3D floating mixed gel culture and a three-stage differentiation procedure. These organoids expressed common breast tissue, luminal, and basal markers, including estrogen receptor, and could be induced to produce milk protein. These results demonstrate that human iPSCs can be directed in vitro toward mammary lineage differentiation.
-
公开(公告)号:US20240050541A1
公开(公告)日:2024-02-15
申请号:US18267408
申请日:2021-12-21
发明人: Stanley C. Jordan , Noriko Ammerman , Ashley Vo , Irene Kim , Sanjeev Kumar
IPC分类号: A61K38/57 , A61K31/5377 , A61K31/522 , A61K31/43 , A61K31/573 , A61P37/06
CPC分类号: A61K38/57 , A61K31/5377 , A61K31/522 , A61K31/43 , A61K31/573 , A61P37/06
摘要: The present invention describes method for reducing Delayed Graft Function (DGF) and Ischemia/Reperfusion Injury (IRI) by intra-renal infusion of a C1 esterase inhibitor.
-
-
-
-
-
-
-
-
-